ADVFN ADVFN

Hot Features

Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Amplia Therapeutics Limited

Amplia Therapeutics Limited (ATXOA)

0.04
0.01
(33.33%)
終了 6月9日 3:00PM

Amplia Therapeutics Limited (ATXOA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.04
( 33.33% )
買値
0.04
売値
0.05
出来高
425,000
0.03 日の範囲 0.04
0.01 52 週間の範囲 0.23
時価総額
前日終値
0.03
始値
0.034
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 4,578,522
発行済株式数
513,312,014
配当利回り
PER
-7.31
1 株当たり利益 (EPS)
-0.02
歳入
4.79M
純利益
-7.71M

Amplia Therapeutics Limited について

Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreati... Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreatic cancer; and treatment of idiopathic pulmonary fibrosis, as well as ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Melbourne, Australia
設立
2026
Amplia Therapeutics Limited is listed in the sector of the オーストラリア証券取引所 with ticker ATXOA. The last closing price for Amplia Therapeutics was AUD0.03. Over the last year, Amplia Therapeutics shares have traded in a share price range of AUD 0.01 to AUD 0.23.

Amplia Therapeutics currently has 513,312,014 shares in issue. The market capitalisation of Amplia Therapeutics is AUD20.53 million. Amplia Therapeutics has a price to earnings ratio (PE ratio) of -7.31.

ATXOA 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.013-24.52830188680.0530.0560.03642490.05002325DE
4-0.02-33.33333333330.060.0730.032614660.05276887DE
120.015600.0250.1350.0235273440.08870144DE
26-0.006-13.04347826090.0460.1350.0233377010.07843286DE
520.028233.3333333330.0120.230.015896200.09728888DE
1560.033000.010.230.0095615490.08447973DE
2600.033000.010.230.0095615490.08447973DE

ATXOA - Frequently Asked Questions (FAQ)

What is the current Amplia Therapeutics Limited share price?
The current share price of Amplia Therapeutics Limited is AUD 0.04
How many Amplia Therapeutics Limited shares are in issue?
Amplia Therapeutics Limited has 513,312,014 shares in issue
What is the market cap of Amplia Therapeutics Limited?
The market capitalisation of Amplia Therapeutics Limited is AUD 20.53M
What is the 1 year trading range for Amplia Therapeutics Limited share price?
Amplia Therapeutics Limited has traded in the range of AUD 0.01 to AUD 0.23 during the past year
What is the PE ratio of Amplia Therapeutics Limited?
The price to earnings ratio of Amplia Therapeutics Limited is -7.31
What is the cash to sales ratio of Amplia Therapeutics Limited?
The cash to sales ratio of Amplia Therapeutics Limited is 12.86
What is the registered address of Amplia Therapeutics Limited?
The registered address for Amplia Therapeutics Limited is 90 William Street, Melbourne, Victoria, 3000
What is the Amplia Therapeutics Limited website address?
The website address for Amplia Therapeutics Limited is www.ampliatx.com

ATXOA 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock